Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness

Blood Cancer J. 2020 Oct 6;10(10):97. doi: 10.1038/s41408-020-00365-4.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Interleukin-17 / genetics*
  • Interleukin-17 / immunology
  • Lymphoma, Follicular / genetics*
  • Lymphoma, Follicular / immunology
  • Lymphoma, Follicular / pathology
  • Male
  • Middle Aged
  • Neoplasm Proteins / genetics*
  • Neoplasm Proteins / immunology
  • Polymorphism, Single Nucleotide*
  • Receptor, Transforming Growth Factor-beta Type II / genetics*
  • Receptor, Transforming Growth Factor-beta Type II / immunology
  • Transforming Growth Factor beta1 / genetics*
  • Transforming Growth Factor beta1 / immunology

Substances

  • IL17A protein, human
  • IL17F protein, human
  • Interleukin-17
  • Neoplasm Proteins
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Receptor, Transforming Growth Factor-beta Type II
  • TGFBR2 protein, human